Lv1
40 积分 2025-09-18 加入
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
1个月前
已完结
Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration
3个月前
已关闭
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
6个月前
已完结
Macrophages and Metabolism in the Tumor Microenvironment
7个月前
已完结
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
7个月前
已完结
Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
7个月前
已完结
Lipid dysregulation in triple negative breast cancer: Insights from mass spectrometry-based approaches
7个月前
已完结
Hepatectomy for Noncolorectal Non-Neuroendocrine Metastatic Cancer: A Multi-Institutional Analysis
7个月前
已完结
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
8个月前
已完结
Spatial landscapes of cancers: insights and opportunities
8个月前
已完结
皖公网安备34019202002308
